Table 2.
Baseline characteristics.
| Procalcitonin group (n = 79) |
Control group (n = 83) |
p value | |
|---|---|---|---|
| Median age (range), years | 56 (36–73) | 57 (36–71) | 0.776 |
| Males, n (%) | 46 (58.2%) | 47 (57%) | 0.875 |
| ASA 1-2, n (%) | 46 (58.2%) | 60 (72.3%) | 0.07 |
| ASA 3-4 | 33 (41.8%) | 23 (27.7%) | |
| Comorbidities, n (%) | |||
| (i) Diabetes mellitus | 4 (5.1%) | 4 (4.8%) | 1.00 |
| (ii) Pulmonary | 13 (16.5%) | 7 (8.4%) | 0.15 |
| (iii) Cardiac | 29 (36.7%) | 34 (41%) | 0.63 |
| (iv) Renal dysfunction | 9 (11.4%) | 8 (9.6%) | 0.80 |
| Needing ICU hospitalization, n (%) | 10 (12.7%) | 10 (12.0%) | 1.00 |
| Mannheim Peritonitis score (points) | |||
| (i) All | 19 (11–25) | 17 (12–26) | 1.00 |
| (ii) Subgroup 1 | 20 (16–26) | 21 (15.5–27.5) | |
| (iii) Subgroup 2 | 15 (10.8–21.3) | 15 (10–21) | |
| (iv) Subgroup 3 | 24.5 (17.8–29) | 28 (21–38) | |
| Peritonitis | 0.91 | ||
| (i) Trouble exsudat | 5 (6.3%) | 7 (8.4%) | |
| (ii) Gastric/duodenal content | 4 (5.1%) | 5 (6.0%) | |
| (iii) Fibrinous | 3 (3.8%) | 3 (3.6%) | |
| (iv) Purulent | 53 (67.1%) | 52 (62.7%) | |
| (v) Fecal | 14 (17.7%) | 16 (19.3%) | |
| Peritonitis quadrants | 0.73 | ||
| 1 | 33 (41.8%) | 28 (33.7%) | |
| 2 | 10 (12.7%) | 14 (16.7%) | |
| 3 | 3 (3.8%) | 2 (2.4%) | |
| 4 | 33 (41.8%) | 39 (47.0%) | |
| Group 1 peritonitis due to GI perforation | 31 | 33 | 0.95 |
| (i) Diverticulitis | 14 | 9 | |
| (ii) Perforated ulcer | 4 | 11 | |
| (iii) Perforation stent/colonoscopy/biopsy | 6 | 5 | |
| (iv) Ischemia–necrosis | 6 | 2 | |
| (v) High-velocity trauma | 0 | 2 | |
| (vi) Perforated tumor | 1 | 1 | |
| (vii) Other | 0 | 3 | |
| Group 2 peritonitis due to appendicitis | 34 | 39 | 0.61 |
| Group 3 postoperative peritonitis | 14 | 11 | 0.43 |
| (i) Anastomotic leakage | 6 | 5 |
ASA: American Society of Anesthesiologists physical status classification system; ICU: intensive care unit.